According to Citeline's Pharmaprojects analysis, the global market for weight loss drugs is expected to grow dramatically from $2.82 billion in 2022 to over $13 billion by 2029
How Tirzepatide Fits Into the Comparison Tirzepatide helps explain why receptor targets matter, but receptor count alone does not rank medicines
GI effects nausea, diarrhea, vomiting, constipation are the most-reported side effects
GutBrain Axis 101: Serotonin, 5HTP & Digestive Signaling Why 90 % of Serotonin Lives in Your Gut GLP-1s affect more than your gut
Sit down, relax the leg, and let the muscle go soft before inserting the needle
Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation